Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm
Crossref DOI link: https://doi.org/10.1007/s00228-017-2301-8
Published Online: 2017-09-11
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Taneja, A.
Della Pasqua, O.
Danhof, M.
Funding for this research was provided by:
This project was supported by the Dutch Top Institute Pharma (TI Pharma).
License valid from 2017-09-11